These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15537363)

  • 1. Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity.
    Wang P; Hollecker L; Pankiewicz KW; Patterson SE; Whitaker T; McBrayer TR; Tharnish PM; Sidwell RW; Stuyver LJ; Otto MJ; Schinazi RF; Watanabe KA
    J Med Chem; 2004 Nov; 47(24):6100-3. PubMed ID: 15537363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of novel anti-hepatitis C agents: N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives.
    Wang P; Du J; Rachakonda S; Chun BK; Tharnish PM; Stuyver LJ; Otto MJ; Schinazi RF; Watanabe KA
    J Med Chem; 2005 Oct; 48(20):6454-60. PubMed ID: 16190771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3'-deoxysugar analogue as potential anti-hepatitis C virus agents.
    Wang P; Hollecker L; Pankiewicz KW; Patterson SE; Whitaker T; McBrayer TR; Tharnish PM; Stuyver LJ; Schinazi RF; Otto MJ; Watanabe KA
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):957-60. PubMed ID: 16248071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
    Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-HCV activity of a new 2'-deoxy-2'-fluoro-2'-C-methyl nucleoside analogue.
    Hu W; Wang P; Song C; Pan Z; Wang Q; Guo X; Yu X; Shen Z; Wang S; Chang J
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7297-8. PubMed ID: 21106452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.
    Sofia MJ; Chang W; Furman PA; Mosley RT; Ross BS
    J Med Chem; 2012 Mar; 55(6):2481-531. PubMed ID: 22185586
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antiviral activity of a series of 1'-substituted 4-aza-7,9-dideazaadenosine C-nucleosides.
    Cho A; Saunders OL; Butler T; Zhang L; Xu J; Vela JE; Feng JY; Ray AS; Kim CU
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2705-7. PubMed ID: 22446091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-HCV activity of 3',4'-oxetane nucleosides.
    Chang W; Du J; Rachakonda S; Ross BS; Convers-Reignier S; Yau WT; Pons JF; Murakami E; Bao H; Steuer HM; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4539-43. PubMed ID: 20580554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral properties of novel tetracyclic nucleoside inhibitors of hepatitis C NS5B polymerase.
    Di Francesco ME; Avolio S; Dessole G; Koch U; Pompei M; Pucci V; Rowley M; Summa V
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(8):592-607. PubMed ID: 22908950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs.
    Madela K; McGuigan C
    Future Med Chem; 2012 Apr; 4(5):625-50. PubMed ID: 22458682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of pyrano[3,4-b]indole-based allosteric inhibitors of HCV NS5B polymerase with in vivo activity.
    Laporte MG; Jackson RW; Draper TL; Gaboury JA; Galie K; Herbertz T; Hussey AR; Rippin SR; Benetatos CA; Chunduru SK; Christensen JS; Coburn GA; Rizzo CJ; Rhodes G; O'Connell J; Howe AY; Mansour TS; Collett MS; Pevear DC; Young DC; Gao T; Tyrrell DL; Kneteman NM; Burns CJ; Condon SM
    ChemMedChem; 2008 Oct; 3(10):1508-15. PubMed ID: 18729128
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism.
    Lougiakis N; Frakolaki E; Karmou P; Pouli N; Marakos P; Madan V; Bartenschlager R; Vassilaki N
    Chem Biol Drug Des; 2017 Sep; 90(3):352-367. PubMed ID: 28245093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise syntheses and HCV NS5B polymerase inhibition of (2'R)-3 and (2'S)-2'-ethynyluridine-10 and related nucleosides.
    Bennett F; Buevich AV; Huang HC; Girijavallabhan V; Kerekes AD; Huang Y; Malikzay A; Smith E; Ferrari E; Senior M; Osterman R; Wang L; Wang J; Pu H; Truong QT; Tawa P; Bogen SL; Davies IW; Weber AE
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5349-5352. PubMed ID: 29056248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-HCV activity Of 2''-beta-hydroxymethylated nucleosides.
    Jeong LS; Yoo BN; Kim HO; Lee KM; Moon HR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):725-8. PubMed ID: 18066889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3'-Deoxy phosphoramidate dinucleosides as improved inhibitors of hepatitis C virus subgenomic replicon and NS5B polymerase activity.
    Priet S; Zlatev I; Barvik I; Geerts K; Leyssen P; Neyts J; Dutartre H; Canard B; Vasseur JJ; Morvan F; Alvarez K
    J Med Chem; 2010 Sep; 53(18):6608-17. PubMed ID: 20799693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside analog inhibitors of hepatitis C virus replication.
    Carroll SS; Olsen DB
    Infect Disord Drug Targets; 2006 Mar; 6(1):17-29. PubMed ID: 16787301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.
    Wyles DL; Kaihara KA; Schooley RT
    Antimicrob Agents Chemother; 2008 May; 52(5):1862-4. PubMed ID: 18332167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective synthesis and biological evaluations of novel 3'-deoxy-4'-azaribonucleosides as inhibitors of hepatitis C virus RNA replication.
    Chiacchio U; Borrello L; Crispino L; Rescifina A; Merino P; Macchi B; Balestrieri E; Mastino A; Piperno A; Romeo G
    J Med Chem; 2009 Jul; 52(13):4054-7. PubMed ID: 19419173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric synthesis of cyclopropyl-fused 2'-C-methylcarbanucleosides as potential anti-HCV agents.
    Jeong LS; Lee JA; Kim HO; Tosh DK; Moon HR; Lee SJ; Lee KM; Sheen YY; Chun MW
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1021-4. PubMed ID: 18058529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.